Table of Contents
Washington University Experience | MYELIN (IMMUNE-MEDIATED) | MS - Tumefactive | 3C11 MS, Tumefactive (Case 3) CD20 20X
There are very few B cells in most of these lesions and, if present, are often restricted to perivascular spaces.
